December 12, 2025
Based on market forecasts, the disease management apps sector will expand from USD 11.30 billion in 2025 to USD 30.25 billion by 2035, experiencing a CAGR of 10.35%.The rising prevalence of chronic disorders and the growing demand for telemedicine dr...
November 01, 2025
According to market projections, the house calls sector is expected to grow from USD 2.69 billion in 2024 to USD 5.23 billion by 2034, reflecting a CAGR of 6.89%. The market is growing due to rising demand for convenient, at-home healthcare services ...
November 17, 2025
According to market projections, the global respiratory disease vaccine market, valued at USD 65.72 billion in 2025, is anticipated to reach USD 98.41 billion by 2035, growing at a CAGR of 4.12% over the next decade. The rising prevalence of respirat...
October 16, 2025
According to forecasts, the global kidney organ-on-a-chip market will grow from USD 192 million in 2024 to USD 1314.52 million by 2034, with an expected CAGR of 21.27%. A rise in CKD cases and advances in materials are fueling the global market. Nort...
November 01, 2025
The global market is driven by a rise in SCD prevalence and R&D activities. North America dominated the market due to the increasing R&D investment from various companies....
November 12, 2025
According to market projections, the global liver disease therapeutics market, valued at USD 26.54 billion in 2025, is anticipated to reach USD 45.25 billion by 2035, growing at a CAGR of 5.48% over the next decade. The liver disease therapeutics mar...
October 15, 2025
Projections indicate that, predictive disease analytics industry is projected to rise from USD 3.12 billion in 2024 to USD 24.23 billion by 2034, reflecting a CAGR of 22.75% over the next decade. The predictive analytics majorly contributes to improv...
November 01, 2025
Market insights predict, the intravenous immunoglobulin industry is expected to grow from USD 17.12 billion in 2024 to USD 40.78 billion by 2034, driven by a CAGR of 9.14%. The rising prevalence of immunological disorders and the increasing awareness...
October 14, 2025
The inhaled therapy in respiratory disease market is valued at USD 11.98 billion in 2025 and expected to reach USD 16.22 billion by 2034 at 3.44% CAGR. Dominant segments include bronchodilators (28%), MDIs (35%), COPD (38%), retail pharmacies (60%), ...
November 01, 2025
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of p...
November 01, 2025
According to market projections, the protein labeling sector is expected to grow from USD 2.67 billion in 2024 to USD 6.02 billion by 2034, reflecting a CAGR of 8.48%. Protein labeling is used in research and diagnosis of various diseases, which driv...
November 01, 2025
Projections indicate that, the global rare disease treatment market will increase from USD 195.21 billion in 2024 to USD 587.08 billion by 2034, experiencing a CAGR of 11.64% over the next 10 years.The rising prevalence of rare diseases and growing r...
December 22, 2025
According to market projections, the microRNA market will increase from $2.05 billion in 2025 to $6.89 billion by 2035, including the dominant market share held by North America at 41.6% in 2025 and the rapidly expanding Asia Pacific region, which is...
November 01, 2025
According to market projections, the huntington's disease treatment sector is expected to grow from USD 664.9 million in 2024 to USD 1409.15 million by 2034, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as t...
November 01, 2025
According to market projections, the lung disease therapeutics sector is expected to grow from USD 91.36 billion in 2024 to USD 165.17 billion by 2034, reflecting a CAGR of 6.1%. Lung disease therapeutics focus on treating conditions like asthma, COP...
November 01, 2025
Market insights predict, the autoimmune disease diagnostics industry is expected to grow from USD 5.75 billion in 2024 to USD 10.5 billion by 2034, driven by a CAGR of 6.22%. Globally, rising incidences and breakthroughs in technologies in autoimmune...
November 01, 2025
According to market projections, the lysosomal storage disease sector is expected to grow from USD 8.61 billion in 2024 to USD 13.91 billion by 2034, reflecting a CAGR of 4.93%. The lysosomal storage disease market is expanding due to increasing...
November 01, 2025
Forecasts suggest that the digital biomarkers market will expand from USD 4.15 billion in 2024 to USD 32.37 billion by 2034, with a CAGR of 22.74% during this period. The rise has been attributed to the growing need for remote patient monitoring serv...
December 26, 2025
According to market projections, the global drug-eluting balloon catheters market, valued at USD 1.42 billion in 2024, is anticipated to reach USD 4.02 billion by 2034, growing at a CAGR of 11.1% over the next decade. The increasing cases of cardiova...
November 01, 2025
Based on market forecasts, the global infectious disease testing market, projected at USD 27.33 billion in 2024, is expected to reach USD 49.74 billion by 2034, growing at a CAGR of 6.24% over the forecast period. The infectious disease testing marke...
December 23, 2025
Market insights predict the global robotic surgery industry will increase from USD 11.83 billion in 2024 to USD 54.66 billion by 2034, achieving a CAGR of 16.54%. In 2024, North America led the market. The increasing number of surgical procedures con...
December 26, 2025
According to market projections, the global topical drug delivery market, valued at USD 247.3 billion in 2024, is anticipated to reach USD 568.65 billion by 2034, growing at a CAGR of 8.76% over the next decade. A widespread increase in cases of di...
November 28, 2025
Projections indicate that, the global organoids and spheroids market will increase from USD 1.22 billion in 2025 to USD 9.77 billion by 2035, experiencing a CAGR of 23.13% over the next 10 years. Advances in genome editing technologies, automation, m...
December 26, 2025
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
November 01, 2025
Based on market forecasts, the inflammatory bowel disease treatment sector will expand from USD 21.01 billion in 2024 to USD 35.88 billion by 2034, experiencing a CAGR of 5.5%. The Inflammatory Bowel Disease (IBD) treatment market focuses on medicati...
November 01, 2025
Market insights predict, the veterinary infectious disease diagnostics industry is expected to grow from USD 2.68 billion in 2024 to USD 5.76 billion by 2034, driven by a CAGR of 7.95%.The growing infectious disease cases and awareness about animal...
December 22, 2025
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 6.88 billion in 2024, is anticipated to reach USD 16.14 billion by 2034, growing at a CAGR of 8.9% over the next decade. In 2023, medi...
December 26, 2025
Projections indicate that, point-of-care infectious disease testing industry is projected to rise from USD 11.9 billion in 2024 to USD 17.75 billion by 2034, reflecting a CAGR of 4.34% over the next decade. The point-of-care infectious disease testin...
December 22, 2025
Based on market forecasts, the chronic obstructive pulmonary disease sector will expand from USD 22.55 billion in 2024 to USD 34.76 billion by 2034, experiencing a CAGR of 4.42%. In 2023, North America led the COPD market, with chronic bronchitis and...
November 01, 2025
Based on market forecasts, the monoclonal antibodies in veterinary health sector will expand from USD 1.23 billion in 2024 to USD 6 billion by 2034, experiencing a CAGR of 17.13%. In 2024, North America led the veterinary monoclonal antibodies market...
November 01, 2025
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory dis...
November 01, 2025
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific show...
November 10, 2025
Market insights predict the global biomarkers industry will increase from USD 108.04 billion in 2025 to USD 366.6 billion by 2034, achieving a CAGR of 14.54%. North America leads with a 46% market share in biomarker research due to strong support and...
November 01, 2025
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more rel...
November 01, 2025
Based on market forecasts, the global chronic disease treatment market, projected at USD 8.37 billion in 2024, is expected to reach USD 38.02 billion by 2034, growing at a CAGR of 16.34% over the forecast period.The rising prevalence of chronic disor...
November 01, 2025
Projections indicate that, the global sandhoff disease treatment market will increase from USD 260 million in 2024 to USD 456.42 million by 2034, experiencing a CAGR of 5.75% over the next 10 years. The Sandhoff disease treatment market is expanding ...
October 07, 2025
According to market projections, the AAV gene therapy sector is expected to grow from USD 2.75 billion in 2024 to USD 78.56 billion by 2034, reflecting a CAGR of 40.1%. This AAV gene therapy market growth is driven by emerging trends and strong deman...
November 01, 2025
Based on market forecasts, the global medical imaging market, projected at USD 41.64 billion in 2024, is expected to reach USD 67.87 billion by 2034, growing at a CAGR of 4.99% over the forecast period. The rising prevalence of chronic disorders, inc...
November 01, 2025
Market insights predict the global medical foods for orphan disease industry will increase from USD 8.84 billion in 2024 to USD 14.65 billion by 2034, achieving a CAGR of 5.2%. The market is growing due to rising health awareness, demand for personal...
November 01, 2025
Projections indicate that, infectious diseases industry is projected to rise from USD 21.74 billion in 2024 to USD 38.19 billion by 2034, reflecting a CAGR of 5.8% over the next decade. The continuous emergence of various pathogens, resulting in pers...
October 28, 2025
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
November 07, 2025
Market insights predict, the metagenomic sequencing industry is expected to grow from USD 2.24 billion in 2024 to USD 7.63 billion by 2034, driven by a CAGR of 13.04%. The rising prevalence of genetic and infectious disorders and the growing demand f...
November 01, 2025
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
November 01, 2025
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com